Mary Sobieski

612 total citations
13 papers, 241 citations indexed

About

Mary Sobieski is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary Sobieski has authored 13 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary Sobieski's work include Melanoma and MAPK Pathways (3 papers), Radiation Therapy and Dosimetry (3 papers) and Computational Drug Discovery Methods (2 papers). Mary Sobieski is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Radiation Therapy and Dosimetry (3 papers) and Computational Drug Discovery Methods (2 papers). Mary Sobieski collaborates with scholars based in United States, India and China. Mary Sobieski's co-authors include Clifford Stephan, Steven H. Lin, Lawrence F. Bronk, Radhe Mohan, David R. Grosshans, Fada Guan, Dragan Mirković, Reza Taleei, Jeffrey Dinh and U Titt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mary Sobieski

12 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Sobieski United States	8	167	134	64	50	34	13	241
Carmen Klein Germany	7	158 0.9×	109 0.8×	75 1.2×	44 0.9×	43 1.3×	7	247
Sandra Curras-Alonso France	3	221 1.3×	161 1.2×	58 0.9×	124 2.5×	37 1.1×	5	306
Samuel Ingram United Kingdom	10	122 0.7×	51 0.4×	90 1.4×	65 1.3×	20 0.6×	14	208
Morgane Dos Santos France	13	281 1.7×	183 1.4×	95 1.5×	150 3.0×	30 0.9×	38	397
Dylan Y. Breitkreutz United States	10	244 1.5×	248 1.9×	66 1.0×	159 3.2×	21 0.6×	20	377
Chizuru Tsuruoka Japan	12	304 1.8×	93 0.7×	157 2.5×	237 4.7×	60 1.8×	35	448
Alisa Kobayashi Japan	13	254 1.5×	120 0.9×	143 2.2×	258 5.2×	40 1.2×	31	424
Benjamin Kroger United States	5	70 0.4×	47 0.4×	74 1.2×	22 0.4×	25 0.7×	12	233
Anne-Catherine Wéra Belgium	11	200 1.2×	97 0.7×	117 1.8×	110 2.2×	25 0.7×	18	372

Countries citing papers authored by Mary Sobieski

Since Specialization

Citations

This map shows the geographic impact of Mary Sobieski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Sobieski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Sobieski more than expected).

Fields of papers citing papers by Mary Sobieski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Sobieski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Sobieski. The network helps show where Mary Sobieski may publish in the future.

Co-authorship network of co-authors of Mary Sobieski

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Sobieski. A scholar is included among the top collaborators of Mary Sobieski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Sobieski. Mary Sobieski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Guan, Fada, Lawrence F. Bronk, M. Kerr, et al.. (2024). Interpreting the biological effects of protons as a function of physical quantity: linear energy transfer or microdosimetric lineal energy spectrum?. Scientific Reports. 14(1). 25181–25181. 9 indexed citations

Wang, Xinjie, Nicolas L. Palaskas, Mary Sobieski, et al.. (2024). Modeling immune checkpoint inhibitor associated myocarditis in vitro and its therapeutic implications. SHILAP Revista de lepidopterología. 10. 100122–100122. 2 indexed citations

Dasari, Santosh K., Reid T. Powell, Mary Sobieski, et al.. (2023). Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.. Journal of Clinical Oncology. 41(16_suppl). 5546–5546.

Fan, Fan, Susmita Ghosh, Reid T. Powell, et al.. (2023). Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo. PLoS ONE. 18(3). e0281063–e0281063. 6 indexed citations

Dasari, Santosh K., Robiya Joseph, Lingegowda S. Mangala, et al.. (2023). Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. International Journal of Molecular Sciences. 24(4). 3915–3915. 7 indexed citations

Bhat, Raksha R., Reid T. Powell, Mary Sobieski, et al.. (2022). Screening of GPCR drugs for repurposing in breast cancer. Frontiers in Pharmacology. 13. 1049640–1049640. 10 indexed citations

Tan, Lin, Barbara Knighton, Mary Sobieski, et al.. (2022). Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas. SHILAP Revista de lepidopterología. 10(1). 6–6. 14 indexed citations

Bronk, Lawrence F., M. Kerr, Mary Sobieski, et al.. (2020). Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns. Scientific Reports. 10(1). 19101–19101. 14 indexed citations

Hollander, Petra den, Shruti Shah, Xinhui Zhou, et al.. (2019). Abstract 4669: Overcoming therapy resistance in stem cell-rich triple negative breast cancer through p38 MAP kinase inhibition. Cancer Research. 79(13_Supplement). 4669–4669. 2 indexed citations

10.

Guan, Fada, Lawrence F. Bronk, U Titt, et al.. (2015). Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy. Scientific Reports. 5(1). 9850–9850. 124 indexed citations

11.

Lin, Steven H., Jing Zhang, Uma Giri, et al.. (2014). A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(7). 965–973. 31 indexed citations

12.

Lin, Steven H., J. Zhang, Uma Giri, et al.. (2013). High Throughput Clonogenic Survival Screen Identifies Novel Radiation Sensitizers for K-ras Mutant Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(2). S651–S651. 3 indexed citations

13.

Ding, Zhiyong, Péter Germán, Shanshan Bai, et al.. (2012). Agents That Stabilize Mutated von Hippel–Lindau (VHL) Protein: Results of a High-Throughput Screen to Identify Compounds That Modulate VHL Proteostasis. SLAS DISCOVERY. 17(5). 572–580. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact